Brussels, 29/11/2022 (Agence Europe) – The European Commission announced on Monday 28 November that the Health Emergency Preparedness and Response Authority (HERA) has mobilised €5 million from the EU budget allocated to the EU4Health programme to support clinical trials for vaccines and treatments against the Sudan strain of the Ebola virus. There is as yet no vaccine or treatment for this strain which is affecting Uganda. €4 million of this sum should meet the funding needs identified by the World Health Organization (WHO) to conduct a vaccine trial. The remaining €1 million will contribute to the therapeutic trial once the clinical trial has finished and been approved. The data collected will be used to support a possible market authorisation. HERA will explore with Member States the production of medicines when they are authorised. (EV)